Cas 1394085-43-8,(3-[1,3]dioxolan-2-yl-4-fluoro-phenyl)-(8-nitro-quinolin-7-yl)-methanol

1394085-43-8

Post Buying Request

Basic information

Product Name: (3-[1,3]dioxolan-2-yl-4-fluoro-phenyl)-(8-nitro-quinolin-7-yl)-methanol
Synonyms: (3-[1,3]dioxolan-2-yl-4-fluoro-phenyl)-(8-nitro-quinolin-7-yl)-methanol
CAS NO:1394085-43-8
Molecular Formula:
Molecular Weight: 370.337
EINECS: N/A
Product Categories: N/A
Mol File: 1394085-43-8.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (3-[1,3]dioxolan-2-yl-4-fluoro-phenyl)-(8-nitro-quinolin-7-yl)-methanol(CAS DataBase Reference)
NIST Chemistry Reference: (3-[1,3]dioxolan-2-yl-4-fluoro-phenyl)-(8-nitro-quinolin-7-yl)-methanol(1394085-43-8)
EPA Substance Registry System: (3-[1,3]dioxolan-2-yl-4-fluoro-phenyl)-(8-nitro-quinolin-7-yl)-methanol(1394085-43-8)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1394085-43-8(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1394085-43-8 Suppliers

Recommended suppliersmore

1394085-43-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1394085-43-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,9,4,0,8 and 5 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1394085-43:
(9*1)+(8*3)+(7*9)+(6*4)+(5*0)+(4*8)+(3*5)+(2*4)+(1*3)=178
178 % 10 = 8
So 1394085-43-8 is a valid CAS Registry Number.

1394085-43-8Upstream product

1394085-43-8Downstream Products

1394085-43-8Relevant articles and documents

Novel Sulfonaminoquinoline Hepcidin Antagonists

-

Page/Page column 167-168, (2012/09/05)

The present invention relates to novel hepcidin antagonists, pharmaceutical compositions comprising them and the use thereof as medicaments for the use in the treatment of iron metabolism disorders, such as, in particular, iron deficiency diseases and anemias, in particular anemias in connection with chronic inflammatory diseases.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1394085-43-8